Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum

Experimental Parasitology

Volumn 128, Issue 4, 2011, Pages 427-432

  Li, Man jun ^a,b   Lei, Jia hui ^a   Wang, Ting ^a   Lu, Sheng jun ^a   Guan, Fei ^a   Liu, Wen qi ^a   Li, Yong long ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

CD4+CD25+ regulatory T cells; Cimetidine; Cytokine; PEGFP Sj26GST DNA vaccine; Schistosoma japonicum

Indexed keywords

CIMETIDINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHISTOSOMIASIS JAPONICA; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, HELMINTH; CELL PROLIFERATION; CIMETIDINE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE TRANSFERASE; HISTAMINE H2 ANTAGONISTS; MICE; MICE, INBRED BALB C; RANDOM ALLOCATION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SPLEEN; T-LYMPHOCYTES; VACCINES, DNA;

MUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 79960563731     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2011.05.012     Document Type: Article

References (35)

1. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nature Reviews Immunology 2007, 7:875-888.
2. Bergquist N.R., Leonardo L.R., Mitchell G.F. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?. Trends in Parasitology 2005, 21:112-117.
3. Bergquist R., Al-Sherbiny M., Barakat R., Olds R. Blueprint for schistosomiasis vaccine development. Acta Tropica 2002, 82:183-192.
4. Brockmeyer N.H., Kreuzfelder E., Guttmann W., Mertins L., Goos M., Ohnhaus E.E. Cimetidine and the immuno-response in healthy volunteers. The Journal of Investigative Dermatology 1989, 93:757-761.
5. Brunkow M.E., Jeffery E.W., Hjirrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genetics 2001, 27:68-73.
6. + T Cells in spleens and mesenteric lymph nodes of mice infected with Schistosoma japonicum. Acta Biochimica et Biophysica Sinica 2006, 38:299-304.
7. Chitsulo L., Engels D., Montresor A., Savioli L. The global status of schistosomiasis and its control. Acta Tropica 2000, 77:41-51.
8. Drabick J.J., Birx-Raybuck D., Odavia R., Redfield R.R., Oster C.N. Cimetidine as an immunoaugmenting agent in advanced HIV infection. Clinical Research 1992, 40:69-76.
9. Elizondo G., Ostrosky-Wegman P. Effects of metronidazole and its metabolites on histamine immunosuppression activity. Life Sciences 1996, 59:285-297.
10. Ershler W.B., Hacker M.P., Burroughs B.J., Moore L., Myers C.F. Cimetidine and the immune response: I. In vivo augmentation of nonspecific and specific immune response. Clinical Immunology and Immunopathology 1983, 26:10-17.
11. Freston J.W. Cimetidine I. Developments, pharmacology, and efficacy. Annals of Internal Medicine 1982, 97:573-580.
12. Gurunathan S., Wu C.Y., Freidag B.L., Seder R.A. DNA vaccines: a key for inducing long-term cellular immunity. Current Opinion in Immunology 2000, 12:442-447.
13. Harder A. Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitology Research 2002, 88:395-397.
14. Jonuleit H., Schmitt E. The regulatory T cell family: distinct subsets and their interrelations. Journal of Immunology 2003, 171:6323-6327.
15. Kang Y., Jin H., Zheng G., Xie Q., Yin J., Yu Y., Xiao C., Zhang X., Chen A., Wang B. The adjuvant effect of levamisole on killed viral vaccines. Vaccine 2005, 23:5543-5550.
16. +T regulatory cells. Nature Immunology 2003, 4:337-342.
17. Kofta W., Wedrychowicz H. C-DNA vaccination against parasitic infections: advantages and disadvantages. Veterinary Parasitology 2001, 100:3-12.
18. Kubota T., Fujiwara H., Ueda Y., Itoh T., Yamashita T., Yoshimura T., Okugawa K., Yamamoto Y., Yano Y., Yamagishi H. Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients. British Journal of Cancer 2002, 86:1257-1261.
19. Kumar A. Cimetidine: an immunomodulator. DICP. The Annals of Pharmacotherapy 1990, 24:289-295.
20. Kurzrock R., Auber M., Mavligit G.M. Cimetidine therapy for herpes simplex virus infections in immunocompromised patients. Clinical and Experimental Dermatology 1987, 12:326-331.
21. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clinical Microbiology Reviews 2008, 21:225-242.
22. + Tregs and prevent development of colitis in mice. Experimental Parasitology 2007, 116:385-389.
23. Natori T., Sata M., Nagai R., Makuuchi M. Cimetidine inhibits angiogenesis and suppresses tumor growth. Biomedicine Pharmacotherapy 2005, 59:56-60.
24. Nishiguchi S., Tamori A., Shiomi S., Enomoto M., Tatsumi N., Koh N., Habu D., Sakaguchi H., Takeda T., Seki S., Nakamura K., Kubo S., Kinoshita H. Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma. Hepato-gastroenterology 2003, 50:460-462.
25. Ross A.G., Sleigh A.C., Li Y., Davis G.M., Williams G.M., Jiang Z., Feng Z., McManus D.P. Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century. Clinical Microbiology Reviews 2001, 14:270-295.
26. Sahasrabudhe D.M., McCune C.S., O'Donnell R.W., Henshaw E.C. Inhibition of suppressor T lymphocytes (Ts) by cimetidine. Journal of Immunology 1987, 138:2760-2763.
27. Salzet M., Capron A., Stefano G.B. Molecular crosstalk in host-parasite relationships: schistosome-and leech-host interactions. Parasitology Today 2000, 16:536-540.
28. Slotwinski R., Wlodarska-Friszke B., Muszynski J. Early results of the studies of the effect of cimetidine on selected parameters of humoral and cellular immunity in patients with peptic ulcer. Polski Tygodnik Lekarski 1990, 45:695-699.
29. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. The Lancet Infectious Diseases 2006, 6:411-425.
30. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. Journal of Immunology 1998, 160:1212-1218.
31. + regulatory T cells on the immune evasion of Schistosoma japonicum. Parasitology Research 2011, 108:477-480.
32. Wang J.P., Su B.W., Ding Z., Du X., Wang B. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells. Biochemical and Biophysical Research Communications 2008, 372:491-496.
33. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
34. Wynn T.A., Jankovic D., Hieny S., Cheever A.W., Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. Journal of Immunology 1995, 154:4701-4709.
35. Yu G.Q., Liu W.Q., Lei J.H., Mo H.M., Chen Y.L., Li Y.L. Protective efficacy of co-immunized with Sj26 DNA and recombinant protein vaccine against Schistosoma japonicum in mice. Chinese Journal of Parasitology and Parasitic Diseases 2006, 24:51-55.